Metformin reduces the risk of poor treatment outcomes among individuals with rifampicin-resistant tuberculosis and type-2 diabetes mellitus

  1. Argita D. Salindri
  2. Mariam Gujabidze
  3. Maia Kipiani
  4. Nino Lomtadze
  5. Nestani Tukvadze
  6. Zaza Avaliani
  7. Henry M. Blumberg
  8. Hardy Kornfeld
  9. Russell R. Kempker
  10. Matthew J. Magee
2 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

We conducted a retrospective cohort study among individuals with rifampicin-resistant tuberculosis and diabetes to determine the association between metformin use and tuberculosis treatment outcomes. We found that individuals with metformin use had a significantly lower risk of poor tuberculosis treatment outcomes (adjusted RR=0.25, 95%CI 0.06 – 0.95) compared to those without.

Related articles

Related articles are currently not available for this article.